Peer-Reviewed Publication American Academy of Neurology EMBARGOED FOR RELEASE UNTIL 4 P.M. ET, MONDAY, DECEMBER 23, 2024 MINNEAPOLIS – A drug recently approved to prevent migraine may start working right away, according to a study published in the December 23, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology. The study looked at...
Tag: <span>migraine drugs</span>
Post
New migraine drugs no better than cheap painkillers: big study
September 21, 2024 Credit: Unsplash/CC0 Public DomainNew, more expensive migraine drugs are no more effective against the throbbing headaches than traditional painkillers, and even performed worse than an older range of treatments called triptans, said a massive global analysis Thursday. Migraines are severe, often disabling headaches which affect at least one in seven adults globally,...
Post
New migraine drugs less effective than previous generation of triptan meds
MigraineA meta-analysis of 137 trials of migraine drugs indicates that the newest class of treatments are less effective than the previous generation of triptan drugs in relieving acute headaches. A study from The BMJ indicates that the newest class of migraine drugs—which includes Pfizer’s Nurtec, AbbVie’s Ubrelvy and Eli Lilly’s Reyvow—is less effective in the...